AGGE Performance — IQ Enhanced Core Bond U.S. ETF
Data updated: 2020-03-27
In the 12 months to Jan 2020 the fund took in a net $145.6M, and assets reached $6.88M.
AGGE Growth of $100
What $100 invested in IQ Enhanced Core Bond U.S. ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Core Bond category average over the same months.
| Period | AGGE | Category average |
|---|---|---|
| Since data start (Aug 2019 – Jan 2020) | $104 | $103 |
AGGE Annual Returns
Calendar-year total returns of IQ Enhanced Core Bond U.S. ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2020 (Jan–Jan) | +0.99% |
| 2019 (Aug–Dec) | +3.02% |
AGGE Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | +1.0% | — | — | — | — | — | — | — | — | — | — | — |
| 2019 | — | — | — | — | — | — | — | +2.0% | −0.2% | +0.4% | +0.8% | +0.1% |
AGGE Risk
Risk measures from monthly returns over Aug 2019 – Jan 2020.
- Best month: +1.98% (Aug 2019)
- Worst month: −0.24% (Sep 2019)
AGGE Fund Flows
Monthly money in and out of IQ Enhanced Core Bond U.S. ETF, from SEC Form N-PORT.
- 12-month net flow: $145.6M
- 12-month gross sales (incl. reinvestments): $28.9M
- Sales ÷ redemptions: -0.25×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jan 2020 | $0 | −$981K | $981K |
| Dec 2019 | $0 | −$20.4M | $20.4M |
| Nov 2019 | $0 | −$18.2M | $18.2M |
| Oct 2019 | $0 | −$17.4M | $17.4M |
| Sep 2019 | $0 | −$18.3M | $18.3M |
| Aug 2019 | $28.9M | −$41.5M | $70.3M |
AGGE Assets Under Management
Net assets of IQ Enhanced Core Bond U.S. ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2020-01-31 | $6.88M |
| 2019-10-31 | $46.58M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.